002524SZSE
🚨 Material Event

Announcement on the Progress of Freezing of Part of the Shares of the Controlling Shareholder

Guangzheng Ophthalmology Co., Ltd.··2 pages

✨ AI Summary

This announcement details the progress of the judicial freezing of shares held by Guangzheng Investment, the controlling shareholder of Guangzheng Ophthalmology. The freezing, totaling 13,259,915 shares, is due to a lawsuit filed by Dongguan Xinxiwang Supply Chain Service Co., Ltd. The company states this will not affect control or operations, but warns of potential forced selling.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Guangzheng Ophthalmology Hospital Group Co., Ltd.

Stock Code: 002524 Stock Abbreviation: Guangzheng Ophthalmology Announcement No.: 2026-036

Announcement on the Progress of Freezing of Part of the Shares of the Controlling Shareholder

The Company and all members of the Board of Directors guarantee the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

On February 7, 2026, Guangzheng Ophthalmology Hospital Group Co., Ltd. (hereinafter referred to as the "Company") disclosed the "Announcement on the Judicial Freezing of Part of the Shares of the Controlling Shareholder" (Announcement No.: 2026-004) on the Juchao Information Network (http://www.cninfo.com.cn). Recently, the Company received a "Letter of Notification from Guangzheng Investment Co., Ltd. Regarding the Judicial Freezing of Part of its Shares in Guangzheng Ophthalmology" (hereinafter referred to as the "Letter of Notification") from its controlling shareholder, Guangzheng Investment Co., Ltd. (hereinafter referred to as "Guangzheng Investment" or the "Controlling Shareholder"). The progress is hereby announced as follows:

I. Background of the Case Involving Share Freezing

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.